The global Over the Counter (OTC) Analgesics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Over the Counter (OTC) Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over the Counter (OTC) Analgesics.

Report Scope

The Over the Counter (OTC) Analgesics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Over the Counter (OTC) Analgesics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Over the Counter (OTC) Analgesics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Over the Counter (OTC) Analgesics Market Report

Report Metric	Details
Report Name	Over the Counter (OTC) Analgesics Market
CAGR	5%
Segment by Type	Tablet Capsule Other
Segment by Application	Retail Pharmacies Hospital Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Johnson & Johnson, AstraZeneca, Novartis, Sun Pharma, Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Sanofi SA, Takeda Pharmaceutical Company Limited.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Over the Counter (OTC) Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Over the Counter (OTC) Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Over the Counter (OTC) Analgesics Market report?

Ans: The main players in the Over the Counter (OTC) Analgesics Market are Pfizer, Johnson & Johnson, AstraZeneca, Novartis, Sun Pharma, Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Sanofi SA, Takeda Pharmaceutical Company Limited.

What are the Application segmentation covered in the Over the Counter (OTC) Analgesics Market report?

Ans: The Applications covered in the Over the Counter (OTC) Analgesics Market report are Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Over the Counter (OTC) Analgesics Market report?

Ans: The Types covered in the Over the Counter (OTC) Analgesics Market report are Tablet, Capsule, Other

1 Over the Counter (OTC) Analgesics Market Overview

1.1 Product Overview and Scope of Over the Counter (OTC) Analgesics

1.2 Over the Counter (OTC) Analgesics Segment by Type

1.2.1 Global Over the Counter (OTC) Analgesics Market Value Comparison by Type (2024-2030)

1.2.2 Tablet

1.2.3 Capsule

1.2.4 Other

1.3 Over the Counter (OTC) Analgesics Segment by Application

1.3.1 Global Over the Counter (OTC) Analgesics Market Value by Application: (2024-2030)

1.3.2 Retail Pharmacies

1.3.3 Hospital Pharmacies

1.3.4 Online Pharmacies

1.4 Global Over the Counter (OTC) Analgesics Market Size Estimates and Forecasts

1.4.1 Global Over the Counter (OTC) Analgesics Revenue 2019-2030

1.4.2 Global Over the Counter (OTC) Analgesics Sales 2019-2030

1.4.3 Global Over the Counter (OTC) Analgesics Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Over the Counter (OTC) Analgesics Market Competition by Manufacturers

2.1 Global Over the Counter (OTC) Analgesics Sales Market Share by Manufacturers (2019-2024)

2.2 Global Over the Counter (OTC) Analgesics Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Over the Counter (OTC) Analgesics Average Price by Manufacturers (2019-2024)

2.4 Global Over the Counter (OTC) Analgesics Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Over the Counter (OTC) Analgesics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Over the Counter (OTC) Analgesics, Product Type & Application

2.7 Over the Counter (OTC) Analgesics Market Competitive Situation and Trends

2.7.1 Over the Counter (OTC) Analgesics Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Over the Counter (OTC) Analgesics Players Market Share by Revenue

2.7.3 Global Over the Counter (OTC) Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Over the Counter (OTC) Analgesics Retrospective Market Scenario by Region

3.1 Global Over the Counter (OTC) Analgesics Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Over the Counter (OTC) Analgesics Global Over the Counter (OTC) Analgesics Sales by Region: 2019-2030

3.2.1 Global Over the Counter (OTC) Analgesics Sales by Region: 2019-2024

3.2.2 Global Over the Counter (OTC) Analgesics Sales by Region: 2025-2030

3.3 Global Over the Counter (OTC) Analgesics Global Over the Counter (OTC) Analgesics Revenue by Region: 2019-2030

3.3.1 Global Over the Counter (OTC) Analgesics Revenue by Region: 2019-2024

3.3.2 Global Over the Counter (OTC) Analgesics Revenue by Region: 2025-2030

3.4 North America Over the Counter (OTC) Analgesics Market Facts & Figures by Country

3.4.1 North America Over the Counter (OTC) Analgesics Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Over the Counter (OTC) Analgesics Sales by Country (2019-2030)

3.4.3 North America Over the Counter (OTC) Analgesics Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Over the Counter (OTC) Analgesics Market Facts & Figures by Country

3.5.1 Europe Over the Counter (OTC) Analgesics Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Over the Counter (OTC) Analgesics Sales by Country (2019-2030)

3.5.3 Europe Over the Counter (OTC) Analgesics Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Over the Counter (OTC) Analgesics Market Facts & Figures by Country

3.6.1 Asia Pacific Over the Counter (OTC) Analgesics Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Over the Counter (OTC) Analgesics Sales by Country (2019-2030)

3.6.3 Asia Pacific Over the Counter (OTC) Analgesics Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Over the Counter (OTC) Analgesics Market Facts & Figures by Country

3.7.1 Latin America Over the Counter (OTC) Analgesics Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Over the Counter (OTC) Analgesics Sales by Country (2019-2030)

3.7.3 Latin America Over the Counter (OTC) Analgesics Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Over the Counter (OTC) Analgesics Market Facts & Figures by Country

3.8.1 Middle East and Africa Over the Counter (OTC) Analgesics Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Over the Counter (OTC) Analgesics Sales by Country (2019-2030)

3.8.3 Middle East and Africa Over the Counter (OTC) Analgesics Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Over the Counter (OTC) Analgesics Sales by Type (2019-2030)

4.1.1 Global Over the Counter (OTC) Analgesics Sales by Type (2019-2024)

4.1.2 Global Over the Counter (OTC) Analgesics Sales by Type (2025-2030)

4.1.3 Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2019-2030)

4.2 Global Over the Counter (OTC) Analgesics Revenue by Type (2019-2030)

4.2.1 Global Over the Counter (OTC) Analgesics Revenue by Type (2019-2024)

4.2.2 Global Over the Counter (OTC) Analgesics Revenue by Type (2025-2030)

4.2.3 Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2019-2030)

4.3 Global Over the Counter (OTC) Analgesics Price by Type (2019-2030)

5 Segment by Application

5.1 Global Over the Counter (OTC) Analgesics Sales by Application (2019-2030)

5.1.1 Global Over the Counter (OTC) Analgesics Sales by Application (2019-2024)

5.1.2 Global Over the Counter (OTC) Analgesics Sales by Application (2025-2030)

5.1.3 Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2019-2030)

5.2 Global Over the Counter (OTC) Analgesics Revenue by Application (2019-2030)

5.2.1 Global Over the Counter (OTC) Analgesics Revenue by Application (2019-2024)

5.2.2 Global Over the Counter (OTC) Analgesics Revenue by Application (2025-2030)

5.2.3 Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2019-2030)

5.3 Global Over the Counter (OTC) Analgesics Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Over the Counter (OTC) Analgesics Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Johnson & Johnson

6.2.1 Johnson & Johnson Corporation Information

6.2.2 Johnson & Johnson Description and Business Overview

6.2.3 Johnson & Johnson Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Johnson & Johnson Over the Counter (OTC) Analgesics Product Portfolio

6.2.5 Johnson & Johnson Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Corporation Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2019-2024)

6.3.4 AstraZeneca Over the Counter (OTC) Analgesics Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Novartis

6.4.1 Novartis Corporation Information

6.4.2 Novartis Description and Business Overview

6.4.3 Novartis Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novartis Over the Counter (OTC) Analgesics Product Portfolio

6.4.5 Novartis Recent Developments/Updates

6.5 Sun Pharma

6.5.1 Sun Pharma Corporation Information

6.5.2 Sun Pharma Description and Business Overview

6.5.3 Sun Pharma Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sun Pharma Over the Counter (OTC) Analgesics Product Portfolio

6.5.5 Sun Pharma Recent Developments/Updates

6.6 Bayer AG

6.6.1 Bayer AG Corporation Information

6.6.2 Bayer AG Description and Business Overview

6.6.3 Bayer AG Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Bayer AG Over the Counter (OTC) Analgesics Product Portfolio

6.6.5 Bayer AG Recent Developments/Updates

6.7 Boehringer Ingelheim International GmbH

6.6.1 Boehringer Ingelheim International GmbH Corporation Information

6.6.2 Boehringer Ingelheim International GmbH Description and Business Overview

6.6.3 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product Portfolio

6.7.5 Boehringer Ingelheim International GmbH Recent Developments/Updates

6.8 GlaxoSmithKline PLC

6.8.1 GlaxoSmithKline PLC Corporation Information

6.8.2 GlaxoSmithKline PLC Description and Business Overview

6.8.3 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2019-2024)

6.8.4 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product Portfolio

6.8.5 GlaxoSmithKline PLC Recent Developments/Updates

6.9 Reckitt Benckiser Group PLC

6.9.1 Reckitt Benckiser Group PLC Corporation Information

6.9.2 Reckitt Benckiser Group PLC Description and Business Overview

6.9.3 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product Portfolio

6.9.5 Reckitt Benckiser Group PLC Recent Developments/Updates

6.10 Sanofi SA

6.10.1 Sanofi SA Corporation Information

6.10.2 Sanofi SA Description and Business Overview

6.10.3 Sanofi SA Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Sanofi SA Over the Counter (OTC) Analgesics Product Portfolio

6.10.5 Sanofi SA Recent Developments/Updates

6.11 Takeda Pharmaceutical Company Limited.

6.11.1 Takeda Pharmaceutical Company Limited. Corporation Information

6.11.2 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Description and Business Overview

6.11.3 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product Portfolio

6.11.5 Takeda Pharmaceutical Company Limited. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Over the Counter (OTC) Analgesics Industry Chain Analysis

7.2 Over the Counter (OTC) Analgesics Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Over the Counter (OTC) Analgesics Production Mode & Process

7.4 Over the Counter (OTC) Analgesics Sales and Marketing

7.4.1 Over the Counter (OTC) Analgesics Sales Channels

7.4.2 Over the Counter (OTC) Analgesics Distributors

7.5 Over the Counter (OTC) Analgesics Customers

8 Over the Counter (OTC) Analgesics Market Dynamics

8.1 Over the Counter (OTC) Analgesics Industry Trends

8.2 Over the Counter (OTC) Analgesics Market Drivers

8.3 Over the Counter (OTC) Analgesics Market Challenges

8.4 Over the Counter (OTC) Analgesics Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim International GmbH

GlaxoSmithKline PLC

Sanofi SA

Takeda Pharmaceutical Company Limited

List of Tables

Table 1. Global Over the Counter (OTC) Analgesics Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Over the Counter (OTC) Analgesics Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Over the Counter (OTC) Analgesics Market Competitive Situation by Manufacturers in 2023

Table 4. Global Over the Counter (OTC) Analgesics Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Over the Counter (OTC) Analgesics Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Over the Counter (OTC) Analgesics Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Over the Counter (OTC) Analgesics Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Over the Counter (OTC) Analgesics Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Over the Counter (OTC) Analgesics, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Over the Counter (OTC) Analgesics, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Over the Counter (OTC) Analgesics, Product Type & Application

Table 12. Global Key Manufacturers of Over the Counter (OTC) Analgesics, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Over the Counter (OTC) Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Analgesics as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Over the Counter (OTC) Analgesics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Over the Counter (OTC) Analgesics Sales by Region (2019-2024) & (K Units)

Table 18. Global Over the Counter (OTC) Analgesics Sales Market Share by Region (2019-2024)

Table 19. Global Over the Counter (OTC) Analgesics Sales by Region (2025-2030) & (K Units)

Table 20. Global Over the Counter (OTC) Analgesics Sales Market Share by Region (2025-2030)

Table 21. Global Over the Counter (OTC) Analgesics Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Over the Counter (OTC) Analgesics Revenue Market Share by Region (2019-2024)

Table 23. Global Over the Counter (OTC) Analgesics Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Over the Counter (OTC) Analgesics Revenue Market Share by Region (2025-2030)

Table 25. North America Over the Counter (OTC) Analgesics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Over the Counter (OTC) Analgesics Sales by Country (2019-2024) & (K Units)

Table 27. North America Over the Counter (OTC) Analgesics Sales by Country (2025-2030) & (K Units)

Table 28. North America Over the Counter (OTC) Analgesics Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Over the Counter (OTC) Analgesics Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Over the Counter (OTC) Analgesics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Over the Counter (OTC) Analgesics Sales by Country (2019-2024) & (K Units)

Table 32. Europe Over the Counter (OTC) Analgesics Sales by Country (2025-2030) & (K Units)

Table 33. Europe Over the Counter (OTC) Analgesics Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Over the Counter (OTC) Analgesics Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Over the Counter (OTC) Analgesics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Over the Counter (OTC) Analgesics Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Over the Counter (OTC) Analgesics Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Over the Counter (OTC) Analgesics Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Over the Counter (OTC) Analgesics Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Over the Counter (OTC) Analgesics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Over the Counter (OTC) Analgesics Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Over the Counter (OTC) Analgesics Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Over the Counter (OTC) Analgesics Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Over the Counter (OTC) Analgesics Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Over the Counter (OTC) Analgesics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Over the Counter (OTC) Analgesics Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Over the Counter (OTC) Analgesics Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Over the Counter (OTC) Analgesics Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Over the Counter (OTC) Analgesics Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Over the Counter (OTC) Analgesics Sales (K Units) by Type (2019-2024)

Table 51. Global Over the Counter (OTC) Analgesics Sales (K Units) by Type (2025-2030)

Table 52. Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2019-2024)

Table 53. Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2025-2030)

Table 54. Global Over the Counter (OTC) Analgesics Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Over the Counter (OTC) Analgesics Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2019-2024)

Table 57. Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2025-2030)

Table 58. Global Over the Counter (OTC) Analgesics Price (US$/Unit) by Type (2019-2024)

Table 59. Global Over the Counter (OTC) Analgesics Price (US$/Unit) by Type (2025-2030)

Table 60. Global Over the Counter (OTC) Analgesics Sales (K Units) by Application (2019-2024)

Table 61. Global Over the Counter (OTC) Analgesics Sales (K Units) by Application (2025-2030)

Table 62. Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2019-2024)

Table 63. Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2025-2030)

Table 64. Global Over the Counter (OTC) Analgesics Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Over the Counter (OTC) Analgesics Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2019-2024)

Table 67. Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2025-2030)

Table 68. Global Over the Counter (OTC) Analgesics Price (US$/Unit) by Application (2019-2024)

Table 69. Global Over the Counter (OTC) Analgesics Price (US$/Unit) by Application (2025-2030)

Table 70. Pfizer Corporation Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Pfizer Over the Counter (OTC) Analgesics Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Johnson & Johnson Corporation Information

Table 76. Johnson & Johnson Description and Business Overview

Table 77. Johnson & Johnson Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Johnson & Johnson Over the Counter (OTC) Analgesics Product

Table 79. Johnson & Johnson Recent Developments/Updates

Table 80. AstraZeneca Corporation Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. AstraZeneca Over the Counter (OTC) Analgesics Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Novartis Corporation Information

Table 86. Novartis Description and Business Overview

Table 87. Novartis Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Novartis Over the Counter (OTC) Analgesics Product

Table 89. Novartis Recent Developments/Updates

Table 90. Sun Pharma Corporation Information

Table 91. Sun Pharma Description and Business Overview

Table 92. Sun Pharma Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Sun Pharma Over the Counter (OTC) Analgesics Product

Table 94. Sun Pharma Recent Developments/Updates

Table 95. Bayer AG Corporation Information

Table 96. Bayer AG Description and Business Overview

Table 97. Bayer AG Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Bayer AG Over the Counter (OTC) Analgesics Product

Table 99. Bayer AG Recent Developments/Updates

Table 100. Boehringer Ingelheim International GmbH Corporation Information

Table 101. Boehringer Ingelheim International GmbH Description and Business Overview

Table 102. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product

Table 104. Boehringer Ingelheim International GmbH Recent Developments/Updates

Table 105. GlaxoSmithKline PLC Corporation Information

Table 106. GlaxoSmithKline PLC Description and Business Overview

Table 107. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product

Table 109. GlaxoSmithKline PLC Recent Developments/Updates

Table 110. Reckitt Benckiser Group PLC Corporation Information

Table 111. Reckitt Benckiser Group PLC Description and Business Overview

Table 112. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product

Table 114. Reckitt Benckiser Group PLC Recent Developments/Updates

Table 115. Sanofi SA Corporation Information

Table 116. Sanofi SA Description and Business Overview

Table 117. Sanofi SA Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Sanofi SA Over the Counter (OTC) Analgesics Product

Table 119. Sanofi SA Recent Developments/Updates

Table 120. Takeda Pharmaceutical Company Limited. Corporation Information

Table 121. Takeda Pharmaceutical Company Limited. Description and Business Overview

Table 122. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product

Table 124. Takeda Pharmaceutical Company Limited. Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Over the Counter (OTC) Analgesics Distributors List

Table 128. Over the Counter (OTC) Analgesics Customers List

Table 129. Over the Counter (OTC) Analgesics Market Trends

Table 130. Over the Counter (OTC) Analgesics Market Drivers

Table 131. Over the Counter (OTC) Analgesics Market Challenges

Table 132. Over the Counter (OTC) Analgesics Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Over the Counter (OTC) Analgesics

Figure 2. Global Over the Counter (OTC) Analgesics Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Over the Counter (OTC) Analgesics Market Share by Type in 2023 & 2030

Figure 4. Tablet Product Picture

Figure 5. Capsule Product Picture

Figure 6. Other Product Picture

Figure 7. Global Over the Counter (OTC) Analgesics Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Over the Counter (OTC) Analgesics Market Share by Application in 2023 & 2030

Figure 9. Retail Pharmacies

Figure 10. Hospital Pharmacies

Figure 11. Online Pharmacies

Figure 12. Global Over the Counter (OTC) Analgesics Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Over the Counter (OTC) Analgesics Market Size (2019-2030) & (US$ Million)

Figure 14. Global Over the Counter (OTC) Analgesics Sales (2019-2030) & (K Units)

Figure 15. Global Over the Counter (OTC) Analgesics Average Price (US$/Unit) & (2019-2030)

Figure 16. Over the Counter (OTC) Analgesics Report Years Considered

Figure 17. Over the Counter (OTC) Analgesics Sales Share by Manufacturers in 2023

Figure 18. Global Over the Counter (OTC) Analgesics Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Over the Counter (OTC) Analgesics Players: Market Share by Revenue in 2023

Figure 20. Over the Counter (OTC) Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Over the Counter (OTC) Analgesics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Over the Counter (OTC) Analgesics Sales Market Share by Country (2019-2030)

Figure 23. North America Over the Counter (OTC) Analgesics Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Over the Counter (OTC) Analgesics Sales Market Share by Country (2019-2030)

Figure 27. Europe Over the Counter (OTC) Analgesics Revenue Market Share by Country (2019-2030)

Figure 28. Germany Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Over the Counter (OTC) Analgesics Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Over the Counter (OTC) Analgesics Revenue Market Share by Region (2019-2030)

Figure 35. China Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Over the Counter (OTC) Analgesics Sales Market Share by Country (2019-2030)

Figure 46. Latin America Over the Counter (OTC) Analgesics Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Over the Counter (OTC) Analgesics Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Over the Counter (OTC) Analgesics Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE Over the Counter (OTC) Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Over the Counter (OTC) Analgesics by Type (2019-2030)

Figure 56. Global Revenue Market Share of Over the Counter (OTC) Analgesics by Type (2019-2030)

Figure 57. Global Over the Counter (OTC) Analgesics Price (US$/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Over the Counter (OTC) Analgesics by Application (2019-2030)

Figure 59. Global Revenue Market Share of Over the Counter (OTC) Analgesics by Application (2019-2030)

Figure 60. Global Over the Counter (OTC) Analgesics Price (US$/Unit) by Application (2019-2030)

Figure 61. Over the Counter (OTC) Analgesics Value Chain

Figure 62. Over the Counter (OTC) Analgesics Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions